Top Abstract Purchase Related
Home
>
Node
>
Subnode

Ifosfamide and etoposide salvage treatment in advanced ovarian cancer

Bruzzone, M.; Campora, E.; Merlini, L.; Giudici, S.; Bottero, G.; Iskra, L.; Donadio, M.; Ferrari, I.; Ragni, N.

Journal of ChemoTherapy 3(5): 332-334

1991

ISSN/ISBN: 1120-009X
PMID: 1809812
Document Number: 374021
Twelve FIGO stage III-IV ovarian cancer patients progressing or relapsing after primary cisplatin-containing combination chemotherapy were treated with ifosfamide and etoposide. Only patients with clinically evaluable disease entered the trial. The 12 patients received a median number of 3 courses (range 1-6). No complete or partial response and two disease stabilizations were observed. Ten patients progressed on therapy. The combination of ifosfamide and etoposide does not appear to be an effective salvage treatment for advanced ovarian cancer.

Document emailed within 1 workday
Secure & encrypted payments

Donato, M.L.; Champlin, R.E.; Wharton, J.T.; Bodurka-Bevers, D.; Gershenson, D. 2000: Intensive-dose ifosfamide and etoposide with filgrastim for cytoreduction before peripheral blood stem cell collection in patients with advanced ovarian cancer European Journal of Gynaecological Oncology 21(3): 241-244
Yazigi, R.; Wild, R.; Madrid, J.; Arraztoa, J. 1984: Ifosfamide treatment of advanced ovarian cancer Obstetrics and Gynecology 63(2): 163-166
Lund, B.; Hansen, O.P.; Hansen, H.H.; Hansen, M. 1992: Combination therapy with carboplatin/cisplatin/ifosfamide/etoposide in ovarian cancer Seminars in Oncology 19(1 Suppl 1: 26-29
Markman, M. 1995: Rationale for examining the combination of paclitaxel and ifosfamide in the treatment of advanced ovarian cancer Seminars in Oncology 22(3 Suppl 6: 88-89
Shirinian, M.; Lee, J.S.; Dhingra, H.H.; Greenberg, J.; Hong, W.K. 1992: Phase II study of cisplatin, ifosfamide, and etoposide combination for advanced non-small cell lung cancer: final report Seminars in Oncology 19(6 Suppl. 12): 58-63
Ikeda, I.; Shuin, T.; Yao, M.; Kubota, Y.; Hosaka, M. 1993: New salvage chemotherapy (cisplatin, adriamycin, bleomycin, methotrexate, etoposide) for advanced nonseminomatous testicular cancer: experience in three cases Hinyokika Kiyo. Acta Urologica Japonica 39(3): 237-242
Uysal, M.; Ozdogan, M.; Kargi, A.; Gunduz, S.; Sezgin Goksu, S.; Murat Tatli, A.; Arslan, D.; Mutlu, H.; Senol Coskun, H.; Bozcuk, H. 2014: Prolonged progression-free survival with maintenance metronomic oral cyclophosphamide and etoposide treatment in macroscopic residual disease or recurrent/advanced stage ovarian cancer Journal of BUON: Official Journal of the Balkan Union of Oncology 19(4): 980-984
Murakami, F.; Kiyozuka, Y.; Nishimura, H.; Imamura, K.; Yakushiji, M.; Noda, T.; Adachi, S.; Ito, K.; Tamori, N.; Shintani, M. 1993: Etoposide/cis-platinum (CDDP) combined chemotherapy for ovarian cancer: evaluation of optimum schedule for CDDP administration in chronic continuous exposure of ovarian cancer cells to low-dose etoposide in vitro Nihon Sanka Fujinka Gakkai Zasshi 45(2): 125-132
Yuki, K.; Kodama, Y.; Emoto, K.; Yukawa, O.; Onda, J.; Uozumi, T. 1989: A case report of advanced malignant mixed germ cell tumor of parasellar origin indicating marked efficacy of a salvage combined chemotherapy of CDDP and etoposide and subsequent chemotherapy using oral etoposide Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(8 Pt 1): 2651-2654
Lee, H-W.; Choi, J-H.; Lim, H-Y.; Park, J.S.; Kim, H.C.; Kang, S.; Oh, Y.T.; Chun, M.; Sheen, S.S.; Oh, Y.J.; Park, K.J.; Hwang, S.C. 2006: The addition of induction chemotherapy with etoposide, ifosfamide, and cisplatin failed to improve therapeutic outcome of concurrent chemoradiotherapy in patients with locally advanced non-small cell lung cancer -- single institution retrospective analysis Neoplasma 53(1): 30-36
Schmoll, H.J.; Bokemeyer, C.; Harstrick, A.; Illiger, H.J.; Metzner, B.; Ruther, U.; Osternamm, A.; Preiss, J.; Wilke, H.; Hohnloser, J. 1992: Dose escalation of cisplatin (P), etoposide (E), and ifosfamide (I) with GM-CSF for advanced germ cell tumors Pathologie-Biologie 39(9): 961
Topuz, E.; Saip, P.; Aydmer, A.; Salihoğlu, Y.; Berkman, S.; Bengisu, E. 1998: Intraperitoneal cisplatin-mitoxantrone and intravenous ifosfamide combination as first-line treatment of ovarian cancer European Journal of Gynaecological Oncology 19(3): 265-270
Thongprasert, S. 2000: Phase Ii study of ifosfamide, carboplatin, etoposide and GM-CSF in small cell lung cancer Journal of the Medical Association of Thailand 83(5): 549-553
Lorigan, P.; Lee, S.M.; Betticher, D.; Woodhead, M.; Weir, D.; Hanley, S.; Hardy, C.; Thatcher, N. 1995: Chemotherapy with vincristine/ifosfamide/carboplatin/etoposide in small cell lung cancer Seminars in Oncology 22(3 Suppl 7: 32-41
Perez, E.A.; Gandara, D.R. 1994: Etoposide/ifosfamide/cisplatin regimens in metastatic non-small cell lung cancer Seminars in Oncology 21(3 Suppl 4: 2-5
Unsal, M.; Erturk, D. 2003: Cisplatin and etoposide alternating ifosfamide, vincristine, epirubicin in small cell lung cancer Saudi Medical Journal 24(6): 628-631
Palackdharry, C.S.; Krigel, R.L. 1994: Dose-intensive ifosfamide/carboplatin/etoposide plus granulocyte-macrophage colony-stimulating factor for non-small cell lung cancer Seminars in Oncology 21(3 Suppl 4: 6-11
Tsukamoto, T.; Yonese, J.; Ishii, N.; Maezawa, T.; Fukui, I. 2002: Successful salvage chemotherapy with gemcitabine, etoposide and cisplatin for metastatic ureteral cancer: a case report Hinyokika Kiyo. Acta Urologica Japonica 48(7): 427-430
Rose, P.G.; Hunter, R.E. 1994: Advanced ovarian cancer in a woman with a family history of ovarian cancer, discovered at referral for prophylactic oophorectomy. A case report Journal of Reproductive Medicine 39(11): 908-910
Simm, S.; Wolna, M. 1973: Results of treatment of advanced stage of ovarian cancer Ginekologia Polska 44(1): 45-50